Literature DB >> 3073072

Etiology and prevalence of hypertension in diabetic patients.

D C Simonson1.   

Abstract

Data from several epidemiologic studies have suggested that the prevalence of hypertension in patients with diabetes mellitus is approximately 1.5-2.0 times greater than in an appropriately matched nondiabetic population. In patients with insulin-dependent diabetes mellitus (IDDM), hypertension is generally not present at the time of diagnosis. As renal insufficiency develops, blood pressure rises and may exacerbate the progression to end-stage renal failure. In non-insulin-dependent diabetes mellitus (NIDDM), many patients are hypertensive at the time of diagnosis. The incidence of hypertension in NIDDM is related to the degree of obesity, advanced age, and extensive atherosclerosis that is typically present, and it probably includes many patients with essential hypertension. Several other pathophysiologic mechanisms also contribute to the genesis and maintenance of hypertension in the patient with diabetes. Hyperglycemia and increases in total-body exchangeable sodium may lead to extracellular fluid accumulation and expansion of the plasma volume. In some patients, alterations in the function of the renin-angiotensin-aldosterone system and vascular sensitivity to vasoactive hormones may also play a role. It has recently been suggested that hyperinsulinemia and insulin resistance may also contribute to the maintenance of an elevated blood pressure because insulin is known to promote sodium retention and enhance sympathetic nervous system activity. The evidence for these hypotheses and their respective contributions to the etiology of hypertension in IDDM and NIDDM are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3073072     DOI: 10.2337/diacare.11.10.821

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  24 in total

1.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Nørgaard; B Feldt-Rasmussen; K Borch-Johnsen; H Saelan; T Deckert
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

Review 2.  Perindopril safety and tolerance in at-risk patients.

Authors:  S Brichard; A E Lambert
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Extracting knowledge from a large primary health care database using a knowledge-based statistical approach.

Authors:  S Chowdhury; R Linnarsson; A Wallgren; B Wallgren; O Wigertz
Journal:  J Med Syst       Date:  1990-08       Impact factor: 4.460

Review 4.  The impact of antidiabetic therapies on cardiovascular disease.

Authors:  Brandy Panunti; Biju Kunhiraman; Vivian Fonseca
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

5.  PREVALENCE OF COEXISTING DIABETES MELLITUS AND HYPERTENSION AMONG DENTAL PATIENTS IN A TERTIARY CARE HOSPITAL.

Authors:  O I Opeodu; B F Adeyemi
Journal:  J West Afr Coll Surg       Date:  2015 Jul-Sep

6.  Prevalence of reduced renal function among diabetic hypertensive patients.

Authors:  Waleed M Sweileh; Ansam F Sawalha; Sa'ed H Zyoud; Samah W Al-Jabi1; Nasr Y Shraim
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2008-11-20

7.  Association of serum calcium with level of blood pressure in type 2 diabetic patients.

Authors:  Saeed Behradmanesh; Hamid Nasri
Journal:  J Nephropathol       Date:  2013-10-01

8.  Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors:  Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal:  Exp Clin Cardiol       Date:  2007

9.  Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial.

Authors:  D Koya; M Haneda; S Inomata; Y Suzuki; D Suzuki; H Makino; K Shikata; Y Murakami; Y Tomino; K Yamada; S I Araki; A Kashiwagi; R Kikkawa
Journal:  Diabetologia       Date:  2009-08-04       Impact factor: 10.122

10.  Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy.

Authors:  L M Hettihewa; S S Jayasinghe; K G Imendra; T P Weerarathna
Journal:  Int J Diabetes Dev Ctries       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.